| 000 | 01879 a2200577 4500 | ||
|---|---|---|---|
| 005 | 20250514004944.0 | ||
| 264 | 0 | _c20010906 | |
| 008 | 200109s 0 0 eng d | ||
| 022 | _a0022-2623 | ||
| 024 | 7 |
_a10.1021/jm0100638 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVerner, E | |
| 245 | 0 | 0 |
_aDevelopment of serine protease inhibitors displaying a multicentered short (<2.3 A) hydrogen bond binding mode: inhibitors of urokinase-type plasminogen activator and factor Xa. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cAug 2001 |
||
| 300 |
_a2753-71 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAmidines _xchemical synthesis |
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 | _aCrystallography, X-Ray |
| 650 | 0 | 4 | _aFactor Xa Inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydrogen Bonding |
| 650 | 0 | 4 |
_aIndoles _xchemical synthesis |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 |
_aSerine Proteinase Inhibitors _xchemical synthesis |
| 650 | 0 | 4 | _aSpectrometry, Fluorescence |
| 650 | 0 | 4 | _aSpectrophotometry, Ultraviolet |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aUrokinase-Type Plasminogen Activator _xantagonists & inhibitors |
| 700 | 1 | _aKatz, B A | |
| 700 | 1 | _aSpencer, J R | |
| 700 | 1 | _aAllen, D | |
| 700 | 1 | _aHataye, J | |
| 700 | 1 | _aHruzewicz, W | |
| 700 | 1 | _aHui, H C | |
| 700 | 1 | _aKolesnikov, A | |
| 700 | 1 | _aLi, Y | |
| 700 | 1 | _aLuong, C | |
| 700 | 1 | _aMartelli, A | |
| 700 | 1 | _aRadika, K | |
| 700 | 1 | _aRai, R | |
| 700 | 1 | _aShe, M | |
| 700 | 1 | _aShrader, W | |
| 700 | 1 | _aSprengeler, P A | |
| 700 | 1 | _aTrapp, S | |
| 700 | 1 | _aWang, J | |
| 700 | 1 | _aYoung, W B | |
| 700 | 1 | _aMackman, R L | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 44 _gno. 17 _gp. 2753-71 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm0100638 _zAvailable from publisher's website |
| 999 |
_c11420971 _d11420971 |
||